Quick Takeaways
- This page summarizes Eric Shroff's Form 3 filing for ABBOTT LABORATORIES (ABT).
- 0 reported transactions and 7 derivative rows are listed below.
- Filing timestamp: 03 Mar 2025, 20:29.
Eric Shroff - 01 Mar 2025 Form 3 Insider Report for ABBOTT LABORATORIES (ABT)
- Signature
- /s/ Eric Shroff by Jessica H. Paik, Attorney-in-Fact
- Issuer symbol
- ABT
- Transactions as of
- 01 Mar 2025
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 03 Mar 2025, 20:29:56 UTC
- Next filing
- 04 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Eric Shroff filed Form 3 for ABBOTT LABORATORIES (ABT) on 03 Mar 2025."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Official SEC Source
See Original Filing
Ownership activity is grounded in SEC Form 3 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ABT | Common shares without par value | 32,532 | 01 Mar 2025 | Direct |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common Shares | 26,971 | $75.90 | Direct | |||||||
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common Shares | 29,020 | $87.72 | Direct | |||||||
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common Shares | 20,045 | $124.04 | Direct | |||||||
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common shares | 20,404 | $117.58 | Direct | |||||||
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common shares | 13,056 | $106.24 | Direct | F1 | ||||||
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common shares | 13,250 | $116.98 | Direct | F2 | ||||||
| holding | ABT | Option (right to buy) | 01 Mar 2025 | Common shares | 27,227 | $135.42 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,352 on February 17, 2024, 4,352 on February 17, 2025, and 4,352 on February 17, 2026. |
| F2 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,416 on February 21, 2025, 4,417 on February 21, 2026, and 4,417 on February 21, 2027. |
| F3 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,075 on February 25, 2026, 9,076 on February 25, 2027, and 9,076 on February 25, 2028. |